PREDIABET ANIQLANGAN BEMORLARDA SCORE-2 YURAK-QON TOMIR ASORATLARI XAVFI SHKALASINING AHAMIYATI HAQIDA
Abstrakt
Tadqiqotning maqsadi prediabetli bemorlarda SCORE-2 yurak-qon tomir xavfi shkalasining qiymatini ko‘rib chiqish va baholashdir. Tadqiqot materiallari va usullari. Tadqiqotda 40 yoshdan 65 yoshgacha bo‘lgan 45 kishi, shu jumladan o‘rtacha yoshi 59,3±8,2 yosh bo‘lgan 25 erkak va o‘rtacha yoshi 55,2±7,1 yosh bo‘lgan 20 nafar ayol ishtirok etdi. . Nazorat guruhi 20 nafar sog'lom odamdan iborat edi. Tadqiqot usullari: umumiy klinik usullar, biokimyoviy tahlillar (qondagi glyukoza darajasi va ovqatdan keyin 2 soat o‘tgach, glyukozalangan gemoglobin, bilirubin, to‘g'ridan-to‘g'ri va bilvosita, ALT, AST, PTI, koagulogramma, C-reaktiv oqsil, karbamid, kreatinin, lipid spektri), qonda gormonal va insulin darajasini o‘rganish usullari (agar kerak bo‘lsa): EKG, endokrin bezlar va ichki organlarning ultratovush tekshiruvi, ko‘krak qafasi rentgenogrammasi va boshqalar. Tadqiqot natijalari. SCORE2 shkalasi yordamida baholanganda, bemorlar xavf guruhlariga bo‘lingan: ulardan 17 nafari past xavf guruhida, 15 nafari o‘rtacha xavf guruhida, 7 nafari yuqori xavf guruhida va 6 nafari juda yuqori xavf guruhida. O‘lim va o‘limga olib kelmaydigan KVHning taxminiy xavfi 0,3% dan 53,2% gacha, o‘rtacha 8,8±7,5% ni tashkil etdi. SCORE2 shkalasiga ko‘ra, barcha bemorlar mos ravishda 18 va 27 bemorni o‘z ichiga olgan yuqori va juda yuqori xavf toifalariga bo‘lingan. Xulosa. 1. Yuqori zichlikdagi lipoproteinlar (HDL bo‘lmagan) xolesterin darajasini hisoblash uchun foydalaniladigan SCORE2 shkalasi o‘zbek etnik guruhida ko‘proq noqulay natijalarni ko‘rsatuvchi individuallashtirilgan xavfni baholash imkonini beradi. SCORE2 tizimi individual yurak-qon tomir xavfini aniqlash uchun yanada tabaqalashtirilgan yondashuvga ega.
Mualliflar haqida
Adabiyotlar ro'yxati
Chipayo-Gonzales D, Ramakrishna H, Nuñez-Gil IJ. Score2: A New Updated Algorithm to Predict Cardiovascular Disease Risk in Europe. J Cardiothorac Vasc Anesth. 2022 Jan;36(1):18-21. doi: 10.1053/j.jvca.2021.09.033.
SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021 Jul 1;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309.
Armstrong K, Berlin M, Schwartz JS, Propert K, Ubel PA. Barriers to influenza immunization in a low-income urban population. Am J Prev Med. 2001 Jan;20(1):21-5. doi: 10.1016/s0749-3797(00)00263-4.
Huang Y, Huang W, Mai W, Cai X, An D, Liu Z, Huang H, Zeng J, Hu Y, Xu D. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017 Apr;35(4):677-688. doi: 10.1097/HJH.0000000000001226
Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297. https://doi.org/10.1136/bmj.m2297.
Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953. https://doi.org/10.1136/bmj.i5953.
Sinha A, Ning H, Ahmad FS, et al. Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project. Cardiovasc Diabetol. 2021;20(1):66. https://doi.org/10.1186/s12933-021-01265-y.
Cai X, Liu X, Sun L, He Y, Zheng S, Zhang Y, et al. Prediabetes and the risk of heart failure: a meta-analysis. Diabetes Obes Metab. 2021. https://doi.org/10.1111/dom.14388.
Pandey A, Vaduganathan M, Patel KV, Ayers C, Ballantyne CM, Kosiborod MN, et al. Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes. JACC Heart Fail. 2021;9(3):215–23. https://doi.org/10.1016/j.jchf.2020.10.013.
Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7(6):452–61. https://doi.org/10.1016/S2213-8587(19)30093-2.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.